An intrastrand d(GpG) platinum crosslink in duplex M13 DNA is refractory to repair by human cell extracts

scientific article published on November 15, 1992

An intrastrand d(GpG) platinum crosslink in duplex M13 DNA is refractory to repair by human cell extracts is …
instance of (P31):
scholarly articleQ13442814

External links are
P819ADS bibcode1992PNAS...8910772S
P356DOI10.1073/PNAS.89.22.10772
P953full work available at URLhttps://europepmc.org/articles/PMC50424
https://europepmc.org/articles/PMC50424?pdf=render
P932PMC publication ID50424
P698PubMed publication ID1438274
P5875ResearchGate publication ID21717992

P50authorDavid E. SzymkowskiQ37838817
P2093author name stringR. D. Wood
J. M. Essigmann
S. J. Lippard
K. Yarema
P2860cites workEnhanced host cell reactivation of damaged plasmid DNA in HeLa cells resistant to cis-diamminedichloroplatinum(II)Q67982271
Transcription by eucaryotic and procaryotic RNA polymerases of DNA modified at a d(GG) or a d(AG) site by the antitumor drug cis-diamminedichloroplatinum(II)Q68183300
Differential repair of platinum-DNA adducts in human bladder and testicular tumor continuous cell linesQ68343885
Reevaluation of interaction of cis-dichloro(ethylenediamine)platinum(II) with DNAQ69586643
In vivo effects of cis- and trans-diamminedichloroplatinum(II) on SV40 chromosomes: differential repair, DNA-protein cross-linking, and inhibition of replicationQ70126283
Increased DNA repair as a mechanism of acquired resistance to cis-diamminedichloroplatinum (II) in human ovarian cancer cell linesQ70404759
Adducts of the antitumor drug cis-diamminedichloroplatinum(II) with DNA: formation, identification, and quantitationQ93607580
Isolation and characterization of human cDNA clones encoding a high mobility group box protein that recognizes structural distortions to DNA caused by binding of the anticancer agent cisplatinQ24562722
Isolation of cDNAs encoding a human protein that binds selectively to DNA modified by the anticancer drug cis-diamminedichloroplatinum(II)Q24604428
Xeroderma pigmentosum group E cells lack a nuclear factor that binds to damaged DNAQ28292106
Drugs five years later. CisplatinQ34257493
Complementation of DNA repair in xeroderma pigmentosum group A cell extracts by a protein with affinity for damaged DNA.Q35935973
Sites of termination of in vitro DNA synthesis on cis-diamminedichloroplatinum(II) treated single-stranded DNA: a comparison between E. coli DNA polymerase I and eucaryotic DNA polymerases alphaQ36005271
Human nucleotide excision nuclease removes thymine dimers from DNA by incising the 22nd phosphodiester bond 5' and the 6th phosphodiester bond 3' to the photodimerQ36968114
Sequence-dependent termination of in vitro DNA synthesis by cis- and trans-diamminedichloroplatinum (II).Q37523234
Replication inhibition and translesion synthesis on templates containing site- specifically placed cis-diamminedichloroplatinum(II) DNA adductsQ38329239
Specific binding of chromosomal protein HMG1 to DNA damaged by the anticancer drug cisplatinQ38329454
DNA unwinding produced by site-specific intrastrand cross-links of the antitumor drug cis-diamminedichloroplatinum(II).Q38333904
Characterization of a DNA damage-recognition protein from mammalian cells that binds specifically to intrastrand d(GpG) and d(ApG) DNA adducts of the anticancer drug cisplatinQ38340395
Substrate overlap and functional competition between human nucleotide excision repair and Escherichia coli photolyase and (a)BC excision nucleaseQ38340400
Bending studies of DNA site-specifically modified by cisplatin, trans-diamminedichloroplatinum(II) and cis-[Pt(NH3)2(N3-cytosine)Cl]+.Q38341322
Chemical and biological studies of the major DNA adduct of cis-diamminedichloroplatinum(II), cis-[Pt(NH3)2(d(GpG]], built into a specific site in a viral genomeQ38347089
Human nucleotide excision repair in vitro: repair of pyrimidine dimers, psoralen and cisplatin adducts by HeLa cell-free extract.Q40450557
Reactions of the UVRABC excision nuclease with DNA damaged by diamminedichloroplatinum(II).Q40472204
Complementation of the xeroderma pigmentosum DNA repair synthesis defect with Escherichia coli UvrABC proteins in a cell-free systemQ40513521
Repair synthesis by human cell extracts in DNA damaged by cis- and trans-diamminedichloroplatinum(II).Q40538207
Effect of the antitumor drug cis-diamminedichloroplatinum(II) and related platinum complexes on eukaryotic DNA replicationQ41202176
Excision repair of cis-diamminedichloroplatinum(II)-induced damage to DNA of Chinese hamster cellsQ41487235
Gene-specific formation and repair of cisplatin intrastrand adducts and interstrand cross-links in Chinese hamster ovary cellsQ41687395
Enhanced DNA repair and tolerance of DNA damage associated with resistance to cis-diammine-dichloroplatinum (II) after in vitro exposure of a human teratoma cell line to fractionated X-irradiation.Q41728494
Localization of DNA repair synthesis by human cell extracts to a short region at the site of a lesion.Q41757759
Identification of inducible damage-recognition proteins that are overexpressed in HeLa cells resistant to cis-diamminedichloroplatinum (II).Q41881603
Formation and repair of cisplatin-induced adducts to DNA in cultured normal and repair-deficient human fibroblasts.Q43484172
DNA excision repair in cell extracts from human cell lines exhibiting hypersensitivity to DNA-damaging agentsQ44551787
Enhanced DNA repair as a mechanism of resistance to cis-diamminedichloroplatinum(II).Q52832659
Efficient synthesis of a supercoiled M13 DNA molecule containing a site specifically placed psoralen adduct and its use as a substrate for DNA replication.Q54235179
Role of carrier ligand in platinum resistance in L1210 cells.Q54313675
Effect of the diaminocyclohexane carrier ligand on platinum adduct formation, repair, and lethality.Q54332081
Specific strand loss in N-2-acetylaminofluorene-modified DNA.Q54767243
Complementation of the xeroderma pigmentosum DNA repair defect in cell-free extracts.Q55060652
Effect of exogenous DNA fragments on human cell extract-mediated DNA repair synthesisQ60311339
Requirement for the replication protein SSB in human DMA excision repairQ60311342
P433issue22
P407language of work or nameEnglishQ1860
P921main subjectplatinumQ880
DNA repairQ210538
P304page(s)10772-10776
P577publication date1992-11-01
1992-11-15
P1433published inProceedings of the National Academy of Sciences of the United States of AmericaQ1146531
P1476titleAn intrastrand d(GpG) platinum crosslink in duplex M13 DNA is refractory to repair by human cell extracts
P478volume89

Reverse relations

cites work (P2860)
Q36785185A new anticancer platinum compound, (-)-(R)-2-aminomethyl-pyrrolidine(1,1-cyclobutanedicarboxylato) platinum(II): DNA interstrand crosslinking, repair and lethal effects in normal human, Fanconi's anaemia and xeroderma pigmentosum cells
Q33893171A rationally designed genotoxin that selectively destroys estrogen receptor-positive breast cancer cells
Q39715713A repair competition assay to assess recognition by human nucleotide excision repair
Q72422002Accumulation of platinum in the intervertebral discs and vertebrae of ovarian tumor-bearing patients treated with cisplatin
Q36566743An XPG DNA repair defect causing mutagen hypersensitivity in mouse leukemia L1210 cells
Q28829273An in vitro method for detecting genetic toxicity based on inhibition of RNA synthesis by DNA lesions
Q36799639Analysis of incision sites produced by human cell extracts and purified proteins during nucleotide excision repair of a 1,3-intrastrand d(GpTpG)-cisplatin adduct
Q33649960Biological properties of single chemical-DNA adducts: a twenty year perspective
Q84593041Cellular uptake and cytoplasm / DNA distribution of cisplatin and oxaliplatin and their liposomal formulation in human colorectal cancer cell HCT116
Q44281098Changes in endogenous tissue glutathione level in relation to murine ascites tumor growth and the anticancer activity of cisplatin
Q41166774Chromatin assembly coupled to DNA repair: a new role for chromatin assembly factor I.
Q41423739Cip1 inhibits DNA replication but not PCNA-dependent nucleotide excision-repair
Q36149816Cisplatin damage: are DNA repair proteins saviors or traitors to the cell?
Q35518363Cisplatin-DNA adducts are molecular decoys for the ribosomal RNA transcription factor hUBF (human upstream binding factor).
Q33635353Current gene expression studies in esophageal carcinoma
Q33601030DNA damage excision repair in microplate wells with chemiluminescence detection: development and perspectives.
Q37358566DNA damage tolerance and a web of connections with DNA repair at Yale
Q34625375Differential human nucleotide excision repair of paired and mispaired cisplatin-DNA adducts
Q54649579Effects of a single intrastrand d(GpG) platinum adduct on the strand separating activity of the Escherichia coli proteins RecB and RecA.
Q28296085Formation and repair of interstrand cross-links in DNA
Q35852579HMG-domain proteins specifically inhibit the repair of the major DNA adduct of the anticancer drug cisplatin by human excision nuclease
Q24561381High-efficiency bypass of DNA damage by human DNA polymerase Q
Q38340847High-mobility group 1 protein inhibits helicase catalyzed displacement of cisplatin-damaged DNA.
Q54462984Human DNA polymerase N (POLN) is a low fidelity enzyme capable of error-free bypass of 5S-thymine glycol.
Q45770163In vitro bypass replication of the cisplatin-d(GpG) lesion by calf thymus DNA polymerase beta and human immunodeficiency virus type I reverse transcriptase is highly mutagenic
Q53712743In vitro enhancement of antitumor activity of a water-soluble duocarmycin derivative, KW-2189, by caffeine-mediated DNA-repair inhibition in human lung cancer cells.
Q40997032Lack of correlation between repair of DNA interstrand cross-links and hypersensitivity of hamster cells towards mitomycin C and cisplatin
Q34282241Mechanisms of resistance to cisplatin
Q34866688Molecular aspects of resistance to antitumor platinum drugs.
Q40400417Mutagenesis in monkey cells of a vector containing a single d(GPG) cis-diamminedichloroplatinum(II) adduct placed on codon 13 of the human H-ras proto-oncogene
Q36591929Overexpression of cyclin B1 antagonizes chemotherapeutic-induced apoptosis through PTEN/Akt pathway in human esophageal squamous cell carcinoma cells
Q34671647Particular aspects of platinum compounds used at present in cancer treatment
Q30755683Photocrosslinking locates a binding site for the large subunit of human replication protein A to the damaged strand of cisplatin-modified DNA
Q33180580Preclinical perspectives on platinum resistance
Q73502663Preferential formation and decreased removal of cisplatin–DNA adducts in Chinese hamster ovary cell mitochondrial DNA as compared to nuclear DNA
Q35888670Rapid gene-specific repair of cisplatin lesions at the human DUG/DHFR locus comprising the divergent upstream gene and dihydrofolate reductase gene during early G1 phase of the cell cycle assayed by using the exonucleolytic activity of T4 DNA polyme
Q41886077Recognition of DNA alterations by the mismatch repair system
Q36615580Repair by human cell extracts of single (6-4) and cyclobutane thymine-thymine photoproducts in DNA
Q43875766Repair of damaged DNA by Arabidopsis cell extract
Q44242635Review of Cisplatin and Oxaliplatin in Current Immunogenic and Monoclonal Antibodies Perspective
Q28082382Review of Cisplatin and oxaliplatin in current immunogenic and monoclonal antibody treatments
Q35009287Role of the human ERCC-1 gene in gene-specific repair of cisplatin-induced DNA damage
Q34625095Selective recognition of a cisplatin-DNA adduct by human mismatch repair proteins.
Q40707413Studying nucleotide excision repair of mammalian DNA in a cell-free system
Q54266410Synthesis, Characterization, and Repair of a Flexible O(6) -2'-Deoxyguanosine-alkylene-O(6) -2'-deoxyguanosine Intrastrand Cross-Link.
Q58318854Transcription factor b (TFIIH) is required during nucleotide-excision repair in yeast
Q33878705Up-regulation of Fas reverses cisplatin resistance of human small cell lung cancer cells
Q39936122Vanillins--a novel family of DNA-PK inhibitors
Q24320768XPG endonuclease makes the 3' incision in human DNA nucleotide excision repair

Search more.